Press Releases Choose Year All Items 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Search Press Releases Found 265 Results March 3, 2015 Relmada Therapeutics to Present at ROTH Capital Partners 27th Annual Growth Stock Conference February 24, 2015 Relmada Therapeutics Announces Filing of Clinical Trial Application in Canada for Novel Oral Formulations of Buprenorphine February 9, 2015 Relmada Therapeutics to Present at the 17th Annual BIO CEO & Investor Conference February 4, 2015 Relmada Therapeutics Selects MepiGel Formulations to Advance Into Clinical Studies January 16, 2015 Relmada Therapeutics to Present at 11th Annual Noble Financial Capital Markets Equity Conference January 13, 2015 Relmada Therapeutics Reaches Midway Point in Dose Escalation for Phase One Study of Novel NMDA Receptor Antagonist d-Methadone January 7, 2015 Relmada Therapeutics to Present at OneMedForum in San Francisco January 6, 2015 Relmada Therapeutics to Provide Corporate Update at 2015 Biotech Showcase™ in San Francisco December 22, 2014 Relmada Therapeutics Doses First Cohort of Subjects in Human Clinical Trial of d-Methadone December 18, 2014 Relmada Therapeutics Announces Results of Annual Shareholders Meeting «...222324252627
